Ziebarth, A. J., Nowsheen, S., Steg, A. D., Shah, M. M., Katre, A. A., Dobbin, Z. C., . . . Landen, C. N. (2012). Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
শিকাগো স্টাইলে সাইটেশনZiebarth, Angela J., et al. Endoglin (CD105) Contributes to Platinum Resistance and Is a Target for Tumor-specific Therapy in Epithelial Ovarian Cancer. 2012.
এমএলএ সাইটেশনZiebarth, Angela J., et al. Endoglin (CD105) Contributes to Platinum Resistance and Is a Target for Tumor-specific Therapy in Epithelial Ovarian Cancer. 2012.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.